Clinical Relevance of Lipid Mediators in Asthma

References

• Sears M R. Epidemiology of asthma. Asthma as an Inflammatory Disease, PM O'Byrne. Marcel Dekker, New York 1990; 1–34
   Google Scholar
• Hargreave F E, Ramsdale E H, Dolovich J. Measurement of airways responsiveness in clinical practice. Airway Responsiveness Measurement and Interpretation, FE Hargreave, AJ Woolcock. Astra Pharmaceuticals, Mississauga 1986; 122–126
   Google Scholar
• Cockcroft D W, Killian D N, Mellon J JA, Hargreave F E. Bronchial reactivity of inhaled histamine: a method and clinical survey. Clin Allergy 1977; 7: 236–243
   Google Scholar
• Ryan G, Latimer K M, Dolovich J, Hargreave F E. Bronchial responsiveness to histamine: Relationship to diurnal variation of peak flow rates and improvement after bronchodilators. Thorax 1982; 37: 423–429
   PubMed Web of Science ®Google Scholar
• Jumper E F, Frith P A, Hargreave F E. Airway responsiveness to histamine and methacholine: Relationship of minimum treatment to control symptoms of asthma. Thorax 1981; 36: 575–579
   PubMedGoogle Scholar
• O'Byrne P M, Kirby J G, Hargreave F E. Airway inflammation and hyperresponsiveness. Am Rev Respir Dis 1987; 136: S35–S37
   Google Scholar
• Osier W. The Principles and Practice of Medicine. Appleton and Co., New York 1892; 497
   Google Scholar
• Dunnill M S, Massarell G R, Anderson J A. A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis and in emphysema. Thorax 1969; 24: 176–179
   PubMed Web of Science ®Google Scholar
• Kirby J G, Hargreave F E, Gleich G J, O'Byrne P M. Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects. Am Rev Respir Dis 1987; 136: 379–383
   PubMed Web of Science ®Google Scholar
• Lee L-Y, Bleeker E R, Nadel J A. Effect of ozone on bronchomotor response to inhaled histamine in dogs. J Appl Physiol 1977; 43: 626–631
   PubMed Web of Science ®Google Scholar
• Murphy K R, Wilson M C, Irvin C G, Glezen L S, Marsh W R, Haslett C, Henson P M, Larsen G L. The requirement for polymorphonuclear leukocytes in the asthmatic response and heightened airways reactivity in an asthmatic model. Am Rev Respir Dis 1986; 134: 62–68
   PubMed Web of Science ®Google Scholar
• Abraham W M, Delehunt J C, Yerger L, Marchette B. Characterization of a late phase pulmonary response after antigen challenge in allergic sheep. Am Rev Respir Dis 1983; 128: 839–844
   PubMed Web of Science ®Google Scholar
• Lewis R A, Austen K F. The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions and pharmacology. J Clin Invest 1984; 73: 889–897
   PubMed Web of Science ®Google Scholar
• O'Byrne P M, Walters E H, Aizawa H, Fabbri L M, Holtzman M J, Nadel J A. Indomethacin inhibits the airway hyperresponsiveness but not the neutrophil influx induced by ozone in dogs. Am Rev Respir Dis 1984; 130: 220–224
   PubMed Web of Science ®Google Scholar
• Fabbri L M, Aizawa H, Cbyrne P M, Bethel R A, Walters E H, Nadel J A, Holtzman M J. An antiinflammatory drug (BW755c) inhibits airway responsiveness induced by ozone in dogs. J Allergy Clin Immunol 1985; 76: 162–166
   PubMedGoogle Scholar
• Berend N, Armour C L, Black J L. Indomethacin inhibits C5a des arg-induced airway hyperresponsiveness in the rabbit. Am Rev Respir Dis 1985; 131: 24A
   Google Scholar
• Lanes S, Stevenson J A, Codias E, Hernandez A, Sialczak M W, Wanner A, Abraham W M. Indomethacin and FPL 55321 inhibit antigen-induced airway hyperresponsiveness in sheep. J Appl Physiol 1986; 61: 864–872
   PubMedGoogle Scholar
• Lee H K, Murlas C. Ozone-induced bronchial hyperreactivity in guinea pigs is abolished by BW 755C or FPL 55712 but not by indomethacin. Am Rev Respir Dis 1985; 132: 1005–1009
   PubMed Web of Science ®Google Scholar
• Fish J E, Ankin M G, Adkinson N J, Peterman V I. Indomethacin modification of immediate-type immunologic airway responses in allergic asthmatic and non-asthmatic subjects. Am Rev Respir Dis 1981; 123: 609–614
   PubMed Web of Science ®Google Scholar
• Fairfax A J. Inhibition of the late asthmatic response to house dust mite by non-steroidal antiinflammatory drugs. Prostaglandins Leukotrienes Med 1982; 8: 239–248
   PubMedGoogle Scholar
• Joubert J R, Shephard E, Mouton W, Van Zyk L, Viljoen I. Non-steroid anti-inflammatory drugs in asthma: dangerous or useful therapy. Allergy 1985; 40: 202–207
   PubMedGoogle Scholar
• Kirby J G, Hargreave F E, Cockcroft D W, O'Byrne P M. The effect of indomethacin on allergen-induced asthmatic responses. J Appl Physiol 1989; 66: 578–583
   PubMed Web of Science ®Google Scholar
• Yen S S, Mathe A A, Dugan J J. Release of prostaglandins from healthy and sensitized guinea-pig lung and trachea by histamine. Prostaglandins 1976; 11: 227–239
   PubMedGoogle Scholar
• Murray J J, Tonnel A B, Brash A R, Roberts L J, Gosset P, Workman R, Capron A, Oates J A. Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med 1986; 315: 800–804
   PubMed Web of Science ®Google Scholar
• Hardy C C, Robinson C, Tattersfield A E, Holgate S T. The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men. N Engl J Med 1984; 311: 209–213
   PubMed Web of Science ®Google Scholar
• Tamaoki J, Sekizawa K, Graf P D, Nadel J A. Cholinergic neuromodulation by prostaglandin D2 in a canine airway smooth muscle. J Appl Physiol 1987; 63: 1396–1400
   PubMed Web of Science ®Google Scholar
• Fuller R W, Dixon C MS, Dollery C T, Barnes P J. Prostaglandin D2 potentiates airway responsiveness to histamine and methacholine. Am Rev Respir Dis 1986; 133: 252–254
   PubMedGoogle Scholar
• O'Byrne P M, Aizawa H, Bethel R A, Chung K F, Nadel J A, Holtzman M J. Prostaglandin F2a increases airway responsiveness of pulmonary airways in dogs. Prostaglandins 1984; 28: 537–543
   PubMedGoogle Scholar
• Fish J E, Jameson A, Albright A, Norman P S. Modulation of bronchomotor effects of chemical mediators by PGF2a. Am Rev Respir Dis 1984; 129: A2
   Google Scholar
• Gardiner P J. Eicosanoids and airway smooth muscle. Pharm Ther 1989; 44: 1–62
   PubMedGoogle Scholar
• Hamberg M, Svensson J, Samuelsson B. Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci (USA) 1975; 72: 2994–2998
   PubMed Web of Science ®Google Scholar
• Higgs G A, Moncada S, Salmon J A, Seager K. The source of thromboxane and prostaglandins in experimental inflammation. Br J Pharmacol 1983; 79: 863–868
   PubMed Web of Science ®Google Scholar
• Aizawa H, Chung K F, Leikauf G D, Ueki I, Bethel R A, O'Byrne P M, Hirose T, Nadel J A. Significance of thromboxane generation in ozone-induced airway hyperresponsiveness in dogs. J Appl Physiol 1918–1923; 59, 1985
   Google Scholar
• Chung K F, Aizawa H, Becker A B, Frick O, Gold W M, Nadel J A. Inhibition of antigen-induced airway hyperresponsiveness by a thromboxane synthetase inhibitor (OKY 046) in allergic dogs. Am Rev Respir Dis 1986; 134: 258–261
   PubMed Web of Science ®Google Scholar
• O'Byrne P M, Leikauf G D, Aizawa H, Bethel R A, Ueki I F, Holtzman M J, Nadel J A. Leukotriene B4 induced airway hyperresponsiveness in dogs. J Appl Physiol 1941–1946; 59, 1985
   Google Scholar
• McFarlane C S, Ford-Hutchinson A W, Letts L G. Inhibition of thromboxane (TxA2)-induced airway hyperresponsiveness to aerosolized acetylcholine by the selective TxA2 antagonist L655,240 in the conscious primate. Am Rev Respir Dis 1988; 137: 100A
   PubMedGoogle Scholar
• Dorsch W D, Ring J, Melzer H. A selective inhibitor of thromboxane biosynthesis enhances immediate and inhibits late cutaneous allergic reactions in man. J Allergy Clin Immunol 1983; 72: 168–174
   PubMedGoogle Scholar
• Kleeberger S R, Kolbe J, Adkinson NF, Jr., Peters S P, Spannhake E W. Thromboxane contributes to the immediate antigenic response of canine peripheral airways. J Appl Physiol 1987; 62: 1589–1595
   PubMedGoogle Scholar
• Shephard E G, Malan L, Macfarlane C M, Mouton W, Joubert J R. Lung function and plasma levels of thromboxane B2, 6-ketoprostaglandin Fla and β-thromboglobulin in antigen-induced asthma before and after indomethacin pretreatment. Br J Clin Pharm 1985; 19: 459–470
   PubMed Web of Science ®Google Scholar
• Fujimura M, Sasaki F, Nakatsumi Y, Takahashi Y, Hifumi S, Taga K, Mifune J-I, Tanaka T, Matsuda T. Effects of a thromboxane synthetase inhibitor (OKY-046) and a lipoxygenase inhibitor (AA-861) on bronchial responsiveness to acetylcholine in asthmatic subjects. Thorax 1986; 41: 955–959
   PubMed Web of Science ®Google Scholar
• Munoz N M, Shioya T, Murphy T M, Primack S, Dame C, Sands M F, Leff A R. Potentiation of vagal contractile response by thromboxane mimetic U-46619. J Appl Physiol 1986; 61: 1173–1179
   PubMed Web of Science ®Google Scholar
• Tamaoki J, Sekizawa K, Osborne M L, Ueki I F, Graf P D, Nadel J A. Platelet aggregation increases cholinergic neurotransmission in canine airway. J Appl Physiol 1987; 62: 2246–2251
   PubMedGoogle Scholar
• Manning P J, Stevens W H, Cockcroft D W, O'Byrne P M. The role of thromboxane in allergen-induced asthmatic responses. Am Rev Respir Dis 1990; 141: A395
   Google Scholar
• O'Byrne P M, Jones G L. The effect of indomethacin on exercise-induced bronchoconstriction and refractoriness after exercise. Am Rev Respir Dis 1986; 134: 69–72
   PubMed Web of Science ®Google Scholar
• Manning P J, Jones G L, O'Byrne P M. Tachyphylaxis to inhaled histamine in asthmatic subjects. J Appl Physiol 1987; 63: 1572–1577
   PubMedGoogle Scholar
• Margolskee D J, Bigby B G, Boushey H A. Indomethacin blocks airway tolerance to repetitive exercise but not to eucapnic hyperpnea in asthmatic subjects. Am Rev Respir Dis 1988; 137: 842–846
   PubMedGoogle Scholar
• Manning P J, Lane C G, O'Byrne P M. The effect of oral prostaglandin E1 on airway responsiveness in asthmatic subjects. Pulmon Pharmacol 1989; 178: 85–89
   Google Scholar
• Anderson W H, Krzanowski J J, Poison J B, Szentivanyi A. Characteristics of histamine tachyphylaxis in canine tracheal smooth muscle. Naunyn-Schiedeberg Arch Pharmacol 1977; 308: 117–125
   Google Scholar
• Shore S, Martin J G. Tachyphylaxis to inhaled aerosolized histamine in anesthetized dogs. J Appl Physiol 1985; 59: 1355–1363
   PubMedGoogle Scholar
• Jackson P A, Manning P J, O'Byrne P M. A new role for histamine H2-receptors in asthmatic airways. Am Rev Respir Dis 1988; 138: 784–788
   PubMedGoogle Scholar
• Maning P M, Jones G L, Lane C G, O'Byrne P M. Histamine-induced prostaglandin E2 release from canine tracheal smooth muscle is inhibited by H2-receptor blockade. Am Rev Respir Dis 1988; 137: 373A
   Google Scholar
• Manning P J, O'Byrne P M. Histamine bronchoconstriction reduces airway responsiveness in asthmatic subjects. Am Rev Respir Dis 1988; 137: 1323–1325
   PubMedGoogle Scholar
• Hamilec C M, Manning P J, O'Byrne P M. Exercise refractoriness post histamine bronchoconstriction in asthmatic subjects. Am Rev Respir Dis 1988; 138: 794–798
   PubMedGoogle Scholar
• Kellaway C H, Trethewie E R. The liberation of a slow-reacting smooth muscle-stimulating substance in anaphylaxis. Q J Exp Physiol 1940; 30: 121–145
   Google Scholar
• Brocklehurst W E. The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock. J Physiol 1960; 151: 416–435
   PubMed Web of Science ®Google Scholar
• Dahlen S E, Hansson G, Hedqyist P, Bjorck T, Gramstrom E, Dahlen B. Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4 and E4. Proc Natl Acad Sci (USA) 1983; 80: 1712–1716
   PubMed Web of Science ®Google Scholar
• Dahlen S E, Hedqvist P, Hammarstrom S, Samuelsson B. Leukotrienes are potent constrictors of human bronchi. Nature 1980; 288: 484–486
   PubMed Web of Science ®Google Scholar
• Griffin M, Weiss J W, Leitch A G, McFadden E R, Corey E J, Austen K F, Drazen J M. Effects of leukotriene D4 on the airways in asthma. IV. Engl J Med 1983; 308: 436–439
   PubMed Web of Science ®Google Scholar
• Smith L J, Greenberger P A, Patterson R, Krell R D, Bernstein P R. The effect of inhaled leukotriene D4 in humans. Am Rev Respir Dis 1985; 131: 368–372
   PubMed Web of Science ®Google Scholar
• Adelroth E, Morris M M, Hargreave F E, O'Byrne P M. Airway responsiveness to leukotrienes C4 and D4 and to methacholine in patients with asthma and normal controls. N Engl J Med 1986; 315: 480–484
   PubMed Web of Science ®Google Scholar
• Barnes N C, Piper P J, Costello J F. Comparative effects of inhaled leukotriene C4, leukotriene D4 and histamine in normal human subjects. Thorax 1984; 39: 500–504
   PubMed Web of Science ®Google Scholar
• Russi A W, Perruchoud A P, Yerger L D, Stevenson J S, Tabak J, Marchette B, Abraham W M. Late phase bronchial obstruction following nonim-munologic mast cell degranulation. J Appl Physiol 1984; 57: 1182–1188
   PubMedGoogle Scholar
• Abraham W M, Rossi E, Wanner A, Delehunt J C, Yerger L D, Chapman G A. Production of early and late pulmonary responses with inhaled leukotriene D4 in allergic sheep. Prostaglandins 1985; 29: 715–727
   PubMedGoogle Scholar
• Higgins D A, O'Byrne P M. Inhaled leukotriene D4 does not cause a late response in atopic subjects. J Allergy Clin Immunol 1987; 79: 141A
   Google Scholar
• O'Byrne P M. Airway inflammation and airway hyperresponsiveness. Chest 1986; 90: 575–577
   PubMedGoogle Scholar
• Holtzman M J, Fabbri L M, O'Byrne P M, Gold B D, Aizawa H, Walters E H, Alpert S E, Nadel J A. Importance of airway inflammation of hyperresponsiveness induced by ozone. Am Rev Respir Dis 1983; 127: 686–690
   PubMed Web of Science ®Google Scholar
• Holtzman M J, Aizawa H, Nadel J A, Goetzl E J. Selective generation of leukotriene B4 by tracheal epithelial cells from dogs. Biochem Biophys Res Commun 1983; 114: 1071–1076
   PubMed Web of Science ®Google Scholar
• Creese B R, Bach M J. Hyperreactivity of airway smooth muscle produced in vitro by leukotrienes. Prostaglandins Leukotrienes Med 1983; 11: 161–169
   PubMedGoogle Scholar
• Lee T H, Austen K F, Corey E J, Drazen J M. Leukotriene E4-induced airway hyperresponsiveness of guinea pig trachea smooth muscle to histamine and evidence for three separate sulfidopeptide leukotriene receptors. Proc Natl Acad Sci (USA) 1984; 81: 4922–1925
   PubMed Web of Science ®Google Scholar
• Stewart A G, Thompson D C, Fennessy M R. Interaction of leukotriene D4 and histamine on bronchomotor tone in the guinea-pig. J Pharm Pharmacol 1983; 35: 755–756
   PubMedGoogle Scholar
• Kern R, Smith L J, Patterson R, Krell R D, Bernstein P R. Characterization of the airway responses to inhaled leukotriene D4 in normal subjects. Am Rev Respir Dis 1986; 133: 1124–1126
   PubMedGoogle Scholar
• Barnes N C, Watson A, Koulouris N, Piper P J, Costello J. Effect of preinhalation of leukotriene D4 on sensitivity to prostaglandin F2a. Thorax 1984; 39: 697
   Google Scholar
• Lee T H, Arm J P, Spur B W. Leukotriene E4 (LTE4) enhances airways histamine responsiveness in asthmatic subjects. J Allergy Clin Immunol 1987; 79: 256 A
   Google Scholar
• Bel E H, Van der Veen H, KrampB JA, Dijkman J H, Sterk P J. Maximal airway narrowing to inhaled leukotriene D4 in normal subjects: comparison and interaction with methacholine. Am Rev Respir Dis 1987; 136: 979–984
   PubMedGoogle Scholar
• Benveniste J, Henson P M, Cochrane C G. J Exp Med 1972; 136: 1356
   PubMed Web of Science ®Google Scholar
• Page C B, Paul W, Archer C B, McDonald D M, Morley J. Platelet Activating Factor, INSERM Symposium 23, J Benveniste, B Arnoux. Elsevier Science, Amsterdam 1983; 357–366
   Google Scholar
• Chrisman B W, Lefferts P L, Snapper J P. Effect of platelet activating factor on aerosol histamine responsiveness in awake sheep. Am Rev Respir Dis 1987; 135: 1267–1270
   PubMedGoogle Scholar
• Lellouch-Tubiana A, Lefort J, Simon M-T, Pfister A, Vargaftig B B. Eosinophil recruitment into guinea pig lungs after PAF-aceter and allergen administration. Am Rev Respir Dis 1988; 137: 948–954
   PubMed Web of Science ®Google Scholar
• Chung K F, Aizawa H, Leikauf G D, Ueki I F, Evens T W, Nadel J A. Airway hyperresponsiveness induced by platelet-activating factor: role of thromboxane generation. J Pharmacol Exp Ther 1986; 236: 580–584
   PubMed Web of Science ®Google Scholar
• Cuss F M, Dixon C MS, Barnes P J. Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet 1986; 2: 189–192
   PubMed Web of Science ®Google Scholar
• Smith L J, Rubin A E, Patterson R. Mechanism of platelet activating factor-induced bronchoconstric-tion in humans. Am Rev Respir Dis 1988; 137: 1015–1019
   PubMed Web of Science ®Google Scholar
• Lai C K, Jenkins J R, Polosa R, Holgate S T. Inhaled PAF fails to induce airway hyperresponsiveness to methacholine in normal human subjects. J Appl Physiol 1990; 68: 919–926
   PubMed Web of Science ®Google Scholar
• Casals-Stenzel J, Muacevic G, Weber K-H. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor. J Pharmacol Exp Ther 1987; 241: 974–981
   PubMed Web of Science ®Google Scholar
• O'Byrne P M. Allergy and airway hyperresponsiveness. The Allergic Basis of Asthma, AB Kay. WB Saunders, London 1988; 127–142
   Google Scholar